|
Market Closed -
Nasdaq
23:00:00 26/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 28.99 USD | -.--% |
|
-.--% | +235.14% |
| 08-31 | AstroNova, Inc.(NasdaqGM:ALOT) dropped from S&P TMI Index | CI |
| 08-28 | AstroNova, Inc.(NasdaqGM:ALOT) dropped from Russell Microcap Growth Benchmark Index | CI |
Company Valuation: ASTRO MED
Data adjusted to current consolidation scope
| Fiscal Period: January | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 77.08 | 99.7 | 97.38 | 131 | 87.33 | 69.43 |
| Change | - | 29.35% | -2.33% | 34.56% | -33.35% | -20.5% |
| Enterprise Value (EV) 1 | 83.94 | 104.7 | 124.3 | 149 | 130.8 | 105.5 |
| Change | - | 24.75% | 18.71% | 19.83% | -12.18% | -19.35% |
| P/E | 59.7x | 15.6x | 36.8x | 28x | -6.01x | -29.1x |
| PBR | 1.03x | 1.23x | 1.15x | 1.45x | 1.15x | 0.91x |
| PEG | - | 0x | -0.6x | 0.4x | 0x | 0.3x |
| Capitalization / Revenue | 0.66x | 0.85x | 0.68x | 0.88x | 0.58x | 0.46x |
| EV / Revenue | 0.72x | 0.89x | 0.87x | 1.01x | 0.86x | 0.7x |
| EV / EBITDA | 9.97x | 20.3x | 12.4x | 9.53x | 12.2x | 10.2x |
| EV / EBIT | 34.5x | 90.6x | 20.2x | 13.1x | 21.9x | 19.2x |
| EV / FCF | 6.24x | -59.9x | -13.8x | 12x | 20x | 7.29x |
| FCF Yield | 16% | -1.67% | -7.25% | 8.33% | 5% | 13.7% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.18 | 0.88 | 0.36 | 0.63 | -1.93 | -0.3121 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 116 | 117.5 | 142.5 | 148.1 | 151.3 | 150.5 |
| EBITDA 1 | 8.416 | 5.15 | 10.06 | 15.64 | 10.74 | 10.3 |
| EBIT 1 | 2.433 | 1.156 | 6.143 | 11.37 | 5.963 | 5.493 |
| Net income 1 | 1.284 | 6.429 | 2.661 | 4.694 | -14.49 | -2.376 |
| Net Debt 1 | 6.855 | 5.013 | 26.92 | 17.91 | 43.47 | 36.07 |
| Reference price 2 | 10.75 | 13.74 | 13.25 | 17.63 | 11.60 | 9.09 |
| Nbr of stocks (in thousands) | 7,170 | 7,256 | 7,350 | 7,433 | 7,529 | 7,638 |
| Announcement Date | 4/13/21 A | 4/18/22 A | 4/17/23 A | 4/12/24 A | 4/15/25 A | 4/15/26 A |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 227M | |
| 19.1x | 1.62x | 12.81x | 0.54% | 297B | |
| 5.78x | 3.04x | 3.77x | -.--% | 184B | |
| 18.44x | 7.41x | 13.51x | 0.46% | 146B | |
| 14.74x | 6.08x | 10.8x | 0.18% | 133B | |
| 20.79x | 1.97x | 10.08x | 0.97% | 77.95B | |
| 28.62x | 5.14x | 15.57x | 0.95% | 43.62B | |
| 134.71x | 8.34x | 36.76x | -.--% | 43.76B | |
| 12.01x | 0.36x | 10.29x | 5.91% | 38.08B | |
| 30.26x | 5.31x | 18.12x | 1.39% | 37.88B | |
| Average | 31.60x | 4.36x | 14.63x | 1.15% | 100.21B | |
| Weighted average by Cap. | 21.72x | 3.89x | 12.04x | 0.65% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALOT Stock
- Valuation ASTRO MED
Select your edition
All financial news and data tailored to specific country editions
